Literature DB >> 12537703

The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system.

Libby Topp1, Louisa Degenhardt, Sharlene Kaye, Shane Darke.   

Abstract

A striking finding of the Illicit Drug Reporting System (IDRS) in recent years has concerned the emergence in Sydney of a number of different forms of potent methamphetamine. This paper demonstrates the operation of the IDRS in detecting and documenting an increase in both the availability and use of these forms of methamphetamine in Sydney, and Australia more widely, since 1998. Data from different components of the IDRS are utilized to propose that there are currently at least three forms of methamphetamine available in Sydney that are considered by the market to be distinct commodities: methamphetamine powder ('speed'), base methamphetamine ('base') and crystalline methamphetamine ('ice'/'shabu'/'crystal meth'). Base and ice are more potent forms of methamphetamine than speed, and international experience, along with preliminary data obtained from the IDRS, suggest that their use is associated with harms in a number of domains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537703     DOI: 10.1080/0959523021000023199

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  10 in total

1.  Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa.

Authors:  Andreas Plüddemann; Alan J Flisher; Rebecca McKetin; Charles Parry; Carl Lombard
Journal:  Drug Alcohol Depend       Date:  2010-01-12       Impact factor: 4.492

2.  Injury associated with methamphetamine use: a review of the literature.

Authors:  Janie Sheridan; Sara Bennett; Carolyn Coggan; Amanda Wheeler; Karen McMillan
Journal:  Harm Reduct J       Date:  2006-03-29

3.  Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents.

Authors:  Mark A Bellis; Karen E Hughes; Paul Dillon; Jan Copeland; Peter Gates
Journal:  BMC Public Health       Date:  2007-01-02       Impact factor: 3.295

4.  Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.

Authors:  Gjalt-Jorn Ygram Peters; Gerjo Kok; Herman P Schaalma
Journal:  BMC Public Health       Date:  2008-10-28       Impact factor: 3.295

5.  Exploring How People Affected by Methamphetamine Exchange Social Support Through Online Interactions on Facebook: Content Analysis.

Authors:  Daniel Ellway; Rachel Reilly; Amanda Le Couteur; James Ward
Journal:  JMIR Ment Health       Date:  2019-10-01

6.  The effect of adolescent social isolation on vulnerability for methamphetamine addiction behaviours in female rats.

Authors:  Paige I Webb; Timothy J Hill; Nicholas A Everett; Jade L Thornton; Jennifer L Cornish; Sarah J Baracz
Journal:  Psychopharmacology (Berl)       Date:  2022-03-26       Impact factor: 4.530

7.  It's time for Canadian community early warning systems for illicit drug overdoses.

Authors:  Sarah J Fielden; David C Marsh
Journal:  Harm Reduct J       Date:  2007-03-28

8.  A Web-Based Toolkit to Provide Evidence-Based Resources About Crystal Methamphetamine for the Australian Community: Collaborative Development of Cracks in the Ice.

Authors:  Katrina Elizabeth Champion; Cath Chapman; Nicola Clare Newton; Mary-Ellen Brierley; Lexine Stapinski; Frances Kay-Lambkin; Jack Nagle; Maree Teesson
Journal:  JMIR Ment Health       Date:  2018-03-20

Review 9.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

10.  Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis.

Authors:  Rebecca McKetin; Janni Leung; Emily Stockings; Yan Huo; James Foulds; Julia M Lappin; Craig Cumming; Shalini Arunogiri; Jesse T Young; Grant Sara; Michael Farrell; Louisa Degenhardt
Journal:  EClinicalMedicine       Date:  2019-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.